Old Web
English
Sign In
Acemap
>
authorDetail
>
Kimberly A Redic
Kimberly A Redic
Medicine
Oncology
Immunology
Refractory Multiple Myeloma
Regimen
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
National Comprehensive Cancer Network investigational drug service consensus recommendations.
2021
American Journal of Health-system Pharmacy
Sapna Amin
Stephen Polley
Sean DeFrates
Heidi D. Finnes
Katharine Kinsman
Elyse MacDonald
Latanya Dean
Lorri DeWitt
Caroline Harvey
Susan Johnston
Tzewah Vivian Leung
Emily A Moll
Gerald P O Neill
Kimberly A Redic
Sharon F Park
Show All
Source
Cite
Save
Citations (0)
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor.
2016
OncoTargets and Therapy
Kimberly A Redic
Shannon Hough
Erika Price
Show All
Source
Cite
Save
Citations (10)
1